Immune checkpoint therapy (ICT) results in durable responses in individuals with some cancers. but not all patients respond to treatment. ICT improves CD8+ cytotoxic T lymphocyte (CTL) function. but changes in tumor antigen-specific CTLs post-ICT that correlate with successful responses have not been well characterized. https://www.pomyslnaszycie.com/